Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia

Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations refractory to bisphosphonates or when kidney function is impaired. It is also...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd Jalil, Afdhal Afiq, Wan Muhamad Hatta, Sharifah Faradila, Mohamad, Aimi Fadilah, Abdul Rani, Mohammed Fauzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079213/
https://www.ncbi.nlm.nih.gov/pubmed/33986809
http://dx.doi.org/10.1155/2021/5544848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079213/
https://www.ncbi.nlm.nih.gov/pubmed/33986809
http://dx.doi.org/10.1155/2021/5544848

Ejemplares similares